Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Methodological issues in the evaluation and monitoring of vaccine safety.
FINE, PE;
1995
Annals of the New York Academy of Sciences, (1995).754, 10.1111/j.1749-6632.1995.tb44463.x.
Invited Commentary on 'Herd Immunity: Basic Concept and Relevance to Public Health Immunization Practices'.
FINE, P;
1995
American Journal of Epidemiology, (1995).141 3 10.1093/oxfordjournals.aje.a117419.
Bacille Calmette-Guérin vaccines: a rough guide.
FINE, PE;
1995
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (1995).20 1 10.1093/clinids/20.1.11.
Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity.
FINE, PE; Sterne, JA; Pönnighaus, JM; Rees, RJ;
1994
Lancet (London, England), (1994).344 8932 10.1016/s0140-6736(94)90748-x.
IgG subclass antibody to Mycobacterium leprae 18,000 MW antigen is restricted to IgG1 and IgG3 in leprosy.
Hussain, R; DOCKRELL, HM; Chiang, TJ;
1994
Immunology, (1994).83 3
Conference report: Vaccination and World Health.
Cutts, FT; SMITH, PG;
1994
Vaccine, (1994).12 15 10.1016/0264-410x(94)90164-3.
Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.
Alonso, PL; Smith, T; SCHELLENBERG, JR; Masanja, H; Mwankusye, S; Urassa, H; Bastos de Azevedo, I; Chongela, J; Kobero, S; Menendez, C;
1994
Lancet (London, England), (1994).344 8931 10.1016/s0140-6736(94)90505-3.
Autoantibodies to cerebroside sulphate (sulphatide) in leprosy.
Wheeler, PR; RAYNES, JG; McAdam, KP;
1994
Clinical and experimental immunology, (1994).98 1 10.1111/j.1365-2249.1994.tb06621.x.
Preparation for phase III HIV vaccine efficacy trials: methods for the determination of HIV incidence.
Heyward, WL; Osmanov, S; Saba, J; Esparza, J; Belsey, E; Stoneburner, R; Kaldor, J; SMITH, PG;
1994
AIDS (London, England), (1994).8 9 10.1097/00002030-199409000-00011.
Assessment of the humoral and cell-mediated immunity against the Plasmodium falciparum vaccine candidates circumsporozoite protein and SPf66 in adults living in highly endemic malarious areas of Papua New Guinea.
Beck, HP; Felger, I; Kabintik, S; Tavul, L; Genton, B; ALEXANDER, N; Bhatia, KK; Al-Yaman, F; Hii, J; Alpers, M;
1994
The American journal of tropical medicine and hygiene, (1994).51 3 10.4269/ajtmh.1994.51.356.